Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
MXCT | US
-0.07
-1.87%
Healthcare
Medical Devices
30/06/2024
04/10/2024
3.67
3.70
3.74
3.59
MaxCyte Inc. a life sciences company discovers develops and commercializes next-generation cell therapies in the United States and internationally. Its products include ExPERT ATx a static electroporation instrument for small to medium scale transfection; ExPERT STx a flow electroporation for protein production and drug development as well as expression of therapeutic targets for cell-based assays; ExPERT GTx a flow electroporation for large scale transfection in therapeutic applications; and ExPERT VLx for very large volume cell-engineering. The company also provides disposable processing assemblies (PAs) to process and electroporate cells; and accessories supporting PAs such as electroporation buffer solution and software protocols. It licenses and sells its instruments and technology; and sells its consumables to developers of cell therapies as well as to pharmaceutical and biotechnology companies for use in drug discovery and development and bio-manufacturing. The company was incorporated in 1998 and is headquartered in Rockville Maryland.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Strong Revenue Growth (> 10%)
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
40.4%1 month
49.1%3 months
59.7%6 months
58.3%-
-
1.84
0.08
0.07
-11.07
6.06
-
-41.92M
390.42M
390.42M
-
-114.76
-
15.30
-15.33
12.25
3.64
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.70
Range1M
0.82
Range3M
1.55
Rel. volume
0.76
Price X volume
927.03K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Butterfly Network Inc. | BFLY | Medical Devices | 1.96 | 416.65M | 10.11% | n/a | 12.34% |
JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares | ZJYL | Medical Instruments & Supplies | 2.51 | 392.93M | -3.83% | 141.50 | 37.91% |
Nano-X Imaging Ltd. | NNOX | Medical Devices | 6.35 | 371.46M | 6.90% | n/a | 4.41% |
Tactile Systems Technology Inc | TCMD | Medical Devices | 14.45 | 346.32M | 1.47% | 10.09 | 23.72% |
Treace Medical Concepts Inc. Common Stock | TMCI | Medical Devices | 5.34 | 332.10M | -2.02% | n/a | 62.29% |
Common Stock | VMD | Medical Devices | 8.355 | 324.39M | 4.83% | 31.70 | 10.44% |
Nyxoah SA | NYXH | Medical Instruments & Supplies | 9.09 | 312.45M | -1.73% | n/a | 10.60% |
Cellpoint Inc | CLPT | Medical Devices | 11.21 | 309.35M | 2.75% | n/a | 42.94% |
OraSure Technologies Inc | OSUR | Medical Instruments & Supplies | 4.14 | 308.71M | -0.24% | 11.92 | 2.96% |
Sight Sciences Inc. | SGHT | Medical Devices | 5.81 | 292.29M | -5.99% | n/a | 34.46% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
The RMR Group Inc | RMR | Real Estate Services | 25.49 | 426.32M | 1.27% | 16.38 | 14.14% |
RE/MAX Holdings Inc | RMAX | Real Estate Services | 11.85 | 372.29M | -4.67% | n/a | 114.28% |
Lincoln Educational Services Corporation | LINC | Building Products & Equipment | 11.63 | 366.05M | 0.00% | 47.92 | 88.92% |
CPI Card Group Inc | PMTS | Building Products & Equipment | 23.62 | 261.38M | 4.61% | 17.90 | -621.78% |
Virco Mfg. Corporation | VIRC | Building Products & Equipment | 13.5 | 219.91M | 1.89% | 8.52 | 39.79% |
STHO | STHO | Real Estate Services | 13 | 173.15M | -3.20% | n/a | 59.21% |
Douglas Elliman Inc. | DOUG | Real Estate Services | 1.66 | 152.44M | -7.26% | n/a | 62.82% |
Comstock Holding Companies Inc | CHCI | Real Estate Services | 11.7 | 115.38M | 14.71% | 11.75 | 17.12% |
Comstock Mining Inc | LODE | Real Estate Services | 0.521 | 107.66M | 21.16% | 6.09 | 14.37% |
OPAD | OPAD | Real Estate Services | 3.39 | 92.73M | -5.31% | n/a | 406.11% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | -11.07 | 45.99 | Cheaper |
Ent. to Revenue | 6.06 | 13.20 | Cheaper |
PE Ratio | - | 29.98 | - |
Price to Book | 1.84 | 6.06 | Cheaper |
Dividend Yield | - | 1.65 | - |
Std. Deviation (3M) | 59.68 | 66.08 | Par |
Debt to Equity | 0.08 | 0.83 | Cheaper |
Debt to Assets | 0.07 | 0.28 | Cheaper |
Market Cap | 390.42M | 9.42B | Emerging |